News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,067 Results
Type
Article (88167)
Company Profile (825)
Press Release (784055)
Multimedia
Podcasts (206)
Webinars (30)
Section
Business (233344)
Career Advice (4152)
Deals (39895)
Drug Delivery (155)
Drug Development (91473)
Employer Resources (205)
FDA (18432)
Job Trends (17439)
News (398113)
Policy (39994)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (163)
Alliances (56982)
ALS (190)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (376)
Approvals (18632)
Artificial intelligence (676)
Autoimmune disease (190)
Automation (47)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (175)
Brain cancer (69)
Breast cancer (693)
Cancer (5313)
Cardiovascular disease (469)
Career advice (3578)
Career pathing (43)
CAR-T (317)
CDC (67)
Celiac Disease (2)
Cell therapy (870)
Cervical cancer (39)
Clinical research (77373)
Collaboration (1938)
Company closure (5)
Compensation (1225)
Complete response letters (79)
COVID-19 (3003)
CRISPR (107)
C-suite (956)
Cystic fibrosis (155)
Data (6645)
Decentralized trials (2)
Denatured (76)
Depression (160)
Diabetes (553)
Diagnostics (7317)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100697)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135778)
Executive appointments (1068)
FDA (21787)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1632)
Gene editing (230)
Generative AI (71)
Gene therapy (713)
GLP-1 (1164)
Government (5479)
Grass and pollen (8)
Guidances (389)
Healthcare (20978)
HIV (76)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (309)
Immuno-oncology (75)
Indications (131)
Infectious disease (3320)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17970)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (73)
Kidney cancer (20)
Labor market (98)
Layoffs (662)
Leadership (44)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (714)
Lymphoma (396)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (15087)
Medtech (15151)
Mergers & acquisitions (23034)
Metabolic disorders (1472)
mRNA (201)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (382)
Neuropsychiatric disorders (108)
Neuroscience (3237)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5121)
Now hiring (70)
Obesity (719)
Opinion (347)
Ovarian cancer (174)
Pain (226)
Pancreatic cancer (250)
Parkinson's disease (317)
Partnered (39)
Patents (545)
Patient recruitment (546)
Peanut (65)
People (67134)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23908)
Phase 2 (33573)
Phase 3 (25294)
Pipeline (5987)
Policy (357)
Postmarket research (3554)
Preclinical (10721)
Press Release (72)
Prostate cancer (272)
Psychedelics (60)
Radiopharmaceuticals (317)
Rare diseases (1001)
Real estate (7445)
Recruiting (81)
Regulatory (29325)
Reports (69)
Research institute (2742)
Resumes & cover letters (653)
Rett syndrome (30)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (117)
Tariffs (101)
The Weekly (128)
Vaccines (1190)
Venture capital (101)
Weight loss (493)
Women's health (104)
Worklife (23)
Date
Today (66)
Last 7 days (968)
Last 30 days (2942)
Last 365 days (32700)
2026 (5380)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (51683)
Australia (9082)
California (12148)
Canada (3460)
China (1227)
Colorado (514)
Connecticut (526)
Delaware (361)
Europe (118903)
Florida (1803)
Georgia (394)
Hawaii (4)
Idaho (68)
Illinois (1009)
India (80)
Indiana (574)
Iowa (24)
Japan (463)
Kansas (135)
Kentucky (47)
Louisiana (32)
Maine (84)
Maryland (1509)
Massachusetts (8897)
Michigan (379)
Minnesota (684)
Mississippi (7)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3266)
New Mexico (33)
New York (3202)
North Carolina (1675)
North Dakota (10)
Northern California (5874)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2417)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4703)
Tennessee (185)
Texas (1909)
United States (43688)
Utah (368)
Vermont (1)
Virginia (306)
Washington D.C. (88)
Washington State (1008)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 873,067 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan
March 2, 2026
·
3 min read
Press Releases
InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China
March 2, 2026
·
3 min read
Press Releases
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
March 2, 2026
·
9 min read
Press Releases
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
March 2, 2026
·
4 min read
Press Releases
Investor Education Webinar
March 2, 2026
·
6 min read
Press Releases
Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
March 2, 2026
·
10 min read
Press Releases
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
March 2, 2026
·
7 min read
Press Releases
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
March 2, 2026
·
8 min read
Press Releases
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
March 2, 2026
·
10 min read
Press Releases
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
March 2, 2026
·
8 min read
1 of 87,307
Next
